StonvexLoading…
StonvexStonvexStonvexCore line items from RRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2022 2022-01-01 | Annual 2021 2021-10-02 |
|---|---|---|---|---|
Revenue | $6.25B | $5.22B | $3.81B | $892.70M |
Operating Income | $377.10M | $690.40M | $358.30M | $107.40M |
Net Income | $-57.40M | $488.90M | $229.60M | $69.50M |
EPS (Diluted) | $-0.87 | $7.29 | $4.81 | $1.70 |
Total Assets | $15.43B | $10.27B | $10.37B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $574.00M | $688.50M | $672.80M | Not available |
Free Cash Flow OCF − CapEx | $596.20M | $352.40M | $303.20M | Not available |
Shares Outstanding | 66.30M | 66.20M | 67.60M | 41.00M |